Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$783,815
+$286,065 QoQ
Shares Held
364,567
+14.3% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. ALEC ranks #270 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $783,815 | 364,567 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $497,750 | 319,072 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,285,134 | 434,168 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $849,169 | 606,552 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $426,445 | 346,707 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,229,520 | 650,541 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $20,297,885 | 4,355,770 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $13,643,028 | 3,005,073 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $19,895,952 | 3,304,976 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $37,108,520 | 4,650,191 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $21,626,257 | 3,337,386 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $10,409,876 | 1,732,093 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,779,070 | 448,962 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,491,475 | 594,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,408,117 | 571,683 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,268,934 | 813,872 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $8,786,776 | 616,616 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $40,025,066 | 1,938,260 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,376,030 | 805,260 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,572,173 | 603,561 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $19,102,063 | 948,464 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,560,371 | 103,131 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,921,423 | 182,385 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,710,921 | 70,005 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,164,006 | 48,239 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||